Hartmut Vatter
Department of Neurosurgery
Goethe-University
Schleusenweg
2-16, Frankfurt/Main D-60528
Germany;
Name/email consistency: high
- Perfusion-diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage. Vatter, H., Güresir, E., Berkefeld, J., Beck, J., Raabe, A., du Mesnil de Rochemont, R., Seifert, V., Weidauer, S. J. Neurol. Neurosurg. Psychiatr. (2011)
- Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels? Vatter, H., Konczalla, J., Seifert, V. Acta Neurochir. Suppl. (2011)
- Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function. Vatter, H., Konczalla, J., Weidauer, S., Preibisch, C., Zimmermann, M., Raabe, A., Seifert, V. J. Neurosurg. (2007)
- Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm. Vatter, H., Konczalla, J., Weidauer, S., Preibisch, C., Raabe, A., Zimmermann, M., Seifert, V. Neurosurgery (2007)
- Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage. Vatter, H., Weidauer, S., Dias, S., Preibisch, C., Ngone, S., Raabe, A., Zimmermann, M., Seifert, V. Neurosurgery (2007)
- Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model. Vatter, H., Weidauer, S., Konczalla, J., Dettmann, E., Zimmermann, M., Raabe, A., Preibisch, C., Zanella, F.E., Seifert, V. Neurosurgery (2006)
- Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist clinically effective for the treatment of cerebral vasospasm. Part I: inhibitory effect on endothelin(A) receptor-mediated contraction. Vatter, H., Zimmermann, M., Tesanovic, V., Raabe, A., Schilling, L., Seifert, V. J. Neurosurg. (2005)
- Cerebrovascular characterization of clazosentan, the first nonpeptide endothelin receptor antagonist shown to be clinically effective for the treatment of cerebral vasospasm. Part II: effect on endothelin(B) receptor-mediated relaxation. Vatter, H., Zimmermann, M., Tesanovic, V., Raabe, A., Seifert, V., Schilling, L. J. Neurosurg. (2005)